图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukaryotGeneExpr.2016017455
pages 353-362

Role of Toll-Like Receptors in Hepatitis C Virus Pathogenesis and Treatment

Usman Ali Ashfaq
Department of Bioinformatics & Biotechnology, Government College University, 38000 Faisalabad, Pakistan
Muhammad Sarfaraz Iqbal
Department of Bioinformatics & Biotechnology, Government College University Faisalabad, Pakistan
Saba Khaliq
University of Health sciences, Lahore

ABSTRACT

Viral infections are rising every day, and viruses appear to be the most dangerous pathogens in the world. Hepatitis C virus (HCV) is accepted as one of the major destructive factors of promoting severe hepatic disorders by infecting more than 180 million individuals throughout the world. Chronic infection caused by HCV poses a serious global health emergency and appears to be a powerful threat to humanity. Almost 20 years have passed since the disclosure of HCV, but even now, treatment preferences remain limited. Humans are born with a rapid and nonspecific mechanism to prevent viral attacks through Toll-like receptors (TLRs), which are evolutionary conserved cellular activator proteins responsible for recognizing specific components present on penetrating microbes and viruses. Recent research efforts in TLR biology suggest that targeting the TLRs and their signaling pathways during HCV infection could contribute to novel therapies against HCV. The mobilization of TLRs boosts antiviral communication and integrates the development of long-lasting acquired immune responses to limit viral pathogenesis. Both activation and suppression of TLRs are necessary for the efficient treatment of HCV. For the proper management and eradication of HCV, novel drugs that target TLRs and their signaling pathway are needed. This review summarizes the role of TLR signaling in HCV infection and treatment.


Articles with similar content:

Mini-Review: The Non-Immune Functions of Toll-Like Receptors
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 1
Li Meng Shou, Li-Yao Ai, Man-Ting Chen, Yun Bei, Ying Song
TSG101: Tumor Susceptibility Gene 101 (tsg101) Product−Role in Therapy Against HIV/AIDS
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 3
Maria Zafar, Muhammad Imran Qadir
Understanding Lung Immunopathology Caused by the Human Metapneumovirus: Implications for Rational Vaccine Design
Critical Reviews™ in Immunology, Vol.35, 2015, issue 3
Claudia A. Riedel, Christian E. Palavecino, Alexis M. Kalergis, Susan M. Bueno, Pablo F. Cespedes, Margarita K. Lay
Toll-Like Receptor Family in Domestic Animal Species
Critical Reviews™ in Immunology, Vol.28, 2008, issue 6
Federica Riva, Lauretta Turin
Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases
Critical Reviews™ in Immunology, Vol.33, 2013, issue 5
Paul J. Bryce, Charles B. Smarr, Stephen D. Miller